Sirnaomics Ltd. (HKG:2257)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.100
+0.010 (0.32%)
May 23, 2025, 3:56 PM HKT
-61.87%
Market Cap 323.46M
Revenue (ttm) 13.81M
Net Income (ttm) -399.12M
Shares Out 104.34M
EPS (ttm) -5.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 219,550
Average Volume 112,205
Open 3.120
Previous Close 3.100
Day's Range 3.080 - 3.130
52-Week Range 2.350 - 8.680
Beta -0.40
RSI 51.95
Earnings Date May 30, 2025

About Sirnaomics

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP122G for the treatment of coagulation disorders;... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 69
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2257
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.